SARS-CoV-2 Adult Vaccine Supply (2026)

Contract for the supply of immunisation products indicated for the prevention of, or protection against, SARS-CoV-2 in Adults (2026). A single contract has been awarded for two Lots: Lot 1, Adult SARS-CoV-2 vaccines with a shelf-life of 10 weeks or greater at 2°C to 8°C & Lot 2, non-mRNA SARS-CoV-2 vaccines, via a further competition conducted under the SARS-CoV-2 vaccine DPS (FTS ref: 2024/S 000-026083). Value - The contract value is withheld from publication pursuant to regulation 50(6)(b) of the Public Contracts Regulations 2015 (as amended) so as not to prejudice the legitimate commercial interest of the supplier.